Trial Profile
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Mar 2014
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Anterios
- 26 Mar 2014 New trial record